Advertisement

Topics

QIAGEN GmbH Company Profile

09:15 EDT 25th May 2018 | BioPortfolio

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of December 31, 2017, QIAGEN employed approximately 4,700 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.


News Articles [265 Associated News Articles listed on BioPortfolio]

DGAP-News: Vara Research GmbH: QIAGEN Q4 2017 Consensus Estimates (deutsch)

Vara Research GmbH: QIAGEN Q4 2017 Consensus Estimates DGAP-News: Vara Research GmbH / Schlagwort(e): Sonstiges Vara Research GmbH: QIAGEN Q4 2017 Consensus Estimates 25.01.2018 / 11:16 Für den In...

DGAP-Adhoc: QIAGEN N.V.: QIAGEN führt Aktienrückkaufprogramm in Höhe von bis zu 200 Millionen US-Dollar durch (deutsch)

QIAGEN N.V.: QIAGEN führt Aktienrückkaufprogramm in Höhe von bis zu 200 Millionen US-Dollar durch DGAP-Ad-hoc: QIAGEN N.V. / Schlagwort(e): Aktienrückkauf QIAGEN N.V.: QIAGEN führt Aktienrückkau...

Vorausschauend kaufen: QIAGEN

Die Neustrukturen in der Biotechnologie zwingen fast jede Firma zu umfangreichen Erweiterungen. Unsere Zurückhaltung gegenüber QIAGEN war bis jetzt richtig. Aber:QIAGEN ist Diagnosespezialist mit S....

QIAGEN führt AdnaTest-Flüssigbiopsiekits für Prostata- und Lungenkrebs ein

Auf der Jahreskonferenz der amerikanischen Krebsforschungsgesellschaft AACR werden über 40 Abstracts zu Sample-to-Insight-Lösungen von QIAGEN veröffentlicht QIAGEN N.V. (NYSE: QGEN; Frankfurt Prim....

Qiagen: Deutliche Belastung durch die Steuerreform

Die Analysten von Independent Research bleiben bei der Halteempfehlung für die Aktien von Qiagen. Das Kursziel für die Papiere von Qiagen sehen die Experten unverändert bei 29,00 Euro. Die Steuerre...

Qiagen: Der unterschätzte Börsen-Altstar!

Lieber Leser, ich habe mich schon in der jüngeren Vergangenheit mehrfach positiv zu Qiagen geäußert und das alles gilt im Grundsatz noch heute. Denn bei Qiagen handelt es sich um einen unterschätz...

Qiagen Aktie: Die Steuerreform in den USA machte Qiagen einen Strich durch die Rechnung!

Liebe Leser, Qiagen hat die eigenen Prognosen für das abgelaufene Jahr mit einem Umsatzwachstum von 7% auf vergleichbarer Basis (ohne Akquisitionen und Währungseffekte) und einem Gewinn vor Sonderf....

QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN's GeneReader NGS System

HILDEN, Germany, and SAN CARLOS, California, March 12, 2018 /PRNewswire/ -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutio...

PubMed Articles [26 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Pre-clinical validation of a next generation sequencing testing panel.

Next Generation Sequencing (NGS) has become a useful tool for gene mutation testing which is required for targeted therapies. The aim of this study was to validate the GeneRead QIAact Actionable Insig...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Clinical Trials [46 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Companies [540 Associated Companies listed on BioPortfolio]

QIAGEN GmbH

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samp...

Plexus Corp.

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological s...

QIAGEN N.V.

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samp...

GenoVision Inc

GenoVision is an innovative biotechnology company with extensive expertise in HLA/tissue typing ranging from sample preparation to advanced analysis. The GenoVision Group was founded in 199...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

More Information about "QIAGEN GmbH" on BioPortfolio

We have published hundreds of QIAGEN GmbH news stories on BioPortfolio along with dozens of QIAGEN GmbH Clinical Trials and PubMed Articles about QIAGEN GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of QIAGEN GmbH Companies in our database. You can also find out about relevant QIAGEN GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record